Fennec Pharmaceuticals Inc. Common Stock

FENC XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

350M

Short interest (May 15)

1.8%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.67%

↑ 4.4%

Available Shares

↑ 3.4%

Price Chart

Company Overview

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001211583

Asset Type: CS

Market Data

Market Cap: $346,675,559

Employees: 35

Status: Active

Short Interest

Current Borrow Fee 0.67%

Range: 0.44% - 0.67%

Available Shares 1M

Range: 1.1M - 1.1M

Recent Changes

Fee Change: ↑ 22.2%

Available Change: ↑ 10.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime